Metaplastic Breast Cancer in a Patient with Neurofibromatosis

Por Chaudhry, Umar Shafique, Yang, Limin, Askeland, Ryan W, Fajardo, Laurie L
Publicado no J Clin Imaging Sci (2015)

Necrotizing granulomatous inflammation in an ipsilateral axillary lymph node in a patient with invasive ductal carcinoma of the breast

Por Yang, Limin, Park, Jeong Mi, Askeland, Ryan W., Fajardo, Laurie L.
Publicado no Radiol Case Rep (2015)

Regulator of G Protein Signaling 6 (RGS6) Induces Apoptosis via a Mitochondrial-dependent Pathway Not Involving Its GTPase-activating Protein Activity

Por Maity, Biswanath, Yang, Jianqi, Huang, Jie, Askeland, Ryan W., Bera, Soumen, Fisher, Rory A.
Publicado em 2011

High TFAP2C/low CD44 expression is associated with an increased rate of pathologic complete response following neoadjuvant chemotherapy in breast cancer

Por Spanheimer, Philip M., Askeland, Ryan W., Kulak, Mikhail V., Wu, Tong, Weigel, Ronald J.
Publicado em 2013

Regulator of G protein signaling 6 is a novel suppressor of breast tumor initiation and progression

Por Maity, Biswanath, Stewart, Adele, O’Malley, Yunxia, Askeland, Ryan W., Sugg, Sonia L., Fisher, Rory A.
Publicado em 2013

Distinct Pathways Regulated by RET and Estrogen Receptor in Luminal Breast Cancer Demonstrate the Biological Basis for Combination Therapy

Por Spanheimer, Philip M., Cyr, Anthony R., Gillum, Matthew P., Woodfield, George W., Askeland, Ryan W., Weigel, Ronald J.
Publicado em 2014

Restructuring the Vocal Fold Lamina Propria with Endoscopic Microdissection

Por Bartlett, Rebecca S., Hoffman, Henry T., Dailey, Seth H., Bock, Jonathan M., Klemuk, Sarah A., Askeland, Ryan W., Ahlrichs-Hanson, Jan S., Heaford, Andrew C., Thibeault, Susan L.
Publicado em 2013

RGS6 is an essential tumor suppressor that prevents bladder carcinogenesis by promoting p53 activation and DNMT1 downregulation

Por Yang, Jianqi, Platt, Lance T., Maity, Biswanath, Ahlers, Katelin E., Luo, Zili, Lin, Zhibo, Chakravarti, Bandana, Ibeawuchi, Stella-Rita, Askeland, Ryan W., Bondaruk, Jolanta, Czerniak, Bogdan A., Fisher, Rory A.
Publicado no Oncotarget (2016)

Inhibition of RET Increases the Efficacy of Anti-Estrogen and is a Novel Treatment Strategy for Luminal Breast Cancer

Por Spanheimer, Philip M., Park, Jung-Min, Askeland, Ryan W., Kulak, Mikhail V., Woodfield, George W., De Andrade, James P., Cyr, Anthony R., Sugg, Sonia L., Thomas, Alexandra, Weigel, Ronald J.
Publicado em 2014

MiR-93 enhances angiogenesis and metastasis by targeting LATS2

Por Fang, Ling, Du, William W., Yang, Weining, Rutnam, Zina Jeyapalan, Peng, Chun, Li, Haoran, O'Malley, Yunxia Q., Askeland, Ryan W., Sugg, Sonia, Liu, Mingyao, Mehta, Tanvi, Deng, Zhaoqun, Yang, Burton B.
Publicado em 2012

RABL6A Promotes Oxaliplatin Resistance in Tumor Cells and Is a New Marker of Survival for Resected Pancreatic Ductal Adenocarcinoma Patients

Por Muniz, Viviane P., Askeland, Ryan W., Zhang, Xuefeng, Reed, Sara M., Tompkins, Van S., Hagen, Jussara, McDowell, Bradley D., Button, Anna, Smith, Brian J., Weydert, Jamie A., Mezhir, James J., Quelle, Dawn E.
Publicado em 2013